PROCEPT BioRobotics Corporation Announces Pricing of Upsized Offering of Common Stock
August 01, 2023 22:10 ET
|
PROCEPT BioRobotics
REDWOOD CITY, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a surgical robotics company focused on advancing patient care by...
PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock
August 01, 2023 16:06 ET
|
PROCEPT BioRobotics
REDWOOD CITY, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a surgical robotics company focused on advancing patient care by...
PROCEPT BioRobotics® Reports Second Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
July 27, 2023 07:00 ET
|
PROCEPT BioRobotics
REDWOOD CITY, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing...
PROCEPT BioRobotics to Report Second Quarter 2023 Financial Results on July 27, 2023
July 11, 2023 16:03 ET
|
PROCEPT BioRobotics
REDWOOD CITY, Calif., July 11, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing...
Five-Year Data from the WATER II Study Demonstrate Aquablation Therapy Delivers Significant Durable Improvement of Benign Prostatic Hyperplasia Symptoms while Preserving Sexual Function in Men with Large Prostates
April 28, 2023 08:00 ET
|
PROCEPT BioRobotics
5-Year results from WATER II when combined with 5-year results from the original WATER study demonstrate that Aquablation therapy provides long-term symptom relief while preserving sexual function for...
PROCEPT BioRobotics Reports First Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
April 27, 2023 07:00 ET
|
PROCEPT BioRobotics
REDWOOD CITY, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing...
PROCEPT BioRobotics to Report First Quarter 2023 Financial Results on April 27, 2023 and Present at the Bank of America 2023 Health Care Conference in Las Vegas
April 05, 2023 16:03 ET
|
PROCEPT BioRobotics
REDWOOD CITY, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing...
PROCEPT BioRobotics Corp. Announces United Healthcare Coverage of Aquablation Therapy for Men with Enlarged Prostates
April 03, 2023 08:00 ET
|
PROCEPT BioRobotics
REDWOOD CITY, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing...
PROCEPT BioRobotics Corp. Announces Investor Event at 2023 AUA Annual Meeting in Chicago
March 30, 2023 16:05 ET
|
PROCEPT BioRobotics
REDWOOD CITY, Calif., March 30, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing...
La terapia Aquablation è il primo sistema di chirurgia robotica a essere oggetto di un MedTech Innovation Briefing (MIB) da parte del National Institute for Health Care Excellence (NICE)
March 07, 2023 23:25 ET
|
PROCEPT BioRobotics
REDWOOD CITY, California, March 08, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation ha annunciato in data odierna che la terapia Aquablation è stata oggetto di un MedTech Innovation...